Rescue of B cells from apoptosis by immune stimulatory CpG DNA

Krieg, Arthur M.; Ae-Kyung Yi
March 2000
Springer Seminars in Immunopathology;2000, Vol. 22 Issue 1/2, p55
Academic Journal
Discusses the regulation of B cells apoptosis by immune stimulatory CpG DNA. Cross-linking of B cell antigen receptor; Biologic consequences of the anti-apoptotic effects of CpG DNA; Enhancement of interferon release.


Related Articles

  • The response of human B lymphocytes to oligodeoxynucleotides. Hua Liang; Lipsky, Peter E. // Springer Seminars in Immunopathology;2000, Vol. 22 Issue 1/2, p63 

    Explores the response of human B lymphocytes to oligodeoxynucleotides (ODN). Adjuvant effect of human monocytes; Production of immunoglobulin from purified B cells; Aberrant mobility of ODN.

  • Effects of Freund's adjuvants on local, draining and circulating lymphocyte populations in sheep. McClure, S. J.; Wagland, B. M.; Emery, D. L. // Immunology & Cell Biology;Dec1991, Vol. 69 Issue 6, p361 

    Lymphatic cannulation and serial biopsy were used to examine changes in cell lymphocyte populations after injection of adjuvant in order to explain the mechanisms of the subversive effect that Freund's adjuvants (FA) have on protective immunity against nematode parasites in sheep. Within 4 days...

  • Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines. Von Bergwelt-Baildon, M. S.; Maecker, B.; Fiore, F.; Nadler, L. M.; Schultze, J. L. // Cancer Cell International;2004 Supplement 1, Vol. 4, pS49 

    The article identifies efficient presentation of antigen in the context of MHC class I and MHC class II as well as homing capabilities to secondary lymphoid organs as essential biological criteria for this cellular adjuvant to merit further development. It shows that antigen-loaded CD40-B cells...

  • The adjuvanticity of gamma inulin. Cooper, Peter D.; Steele, Edward J. // Immunology & Cell Biology;Oct-Dec1988, Vol. 66 Issue 5/6, p345 

    Gamma-inulin (g-IN) is a polymorph identified as the active component of inulin preparations that specifically activates the alternative pathway of complement (APC). The APC is central to many leucocyte functions, including B cell activation. We show here that g-IN, when formulated as a pure,...

  • A novel concept in mucosal adjuvanticity: The CTA1-DD adjuvant is a B cell-targeted fusion.... ÅGREN, LENA; LÖWENADLER, BJÖRN; LYCKE, NILS; Lycke // Immunology & Cell Biology;Jun1998, Vol. 76 Issue 3, p280 

    A promising novel concept in mucosal adjuvant research is demonstrated here. The adjuvant and toxic effects of the cholera toxin (CT) have been successfully separated in a gene fusion protein, CTA1-DD. This protein consists of the ADP-ribosylating A1 subunit of CT linked to a synthetic analogue...

  • DNA released from dying host cells mediates aluminum adjuvant activity. Marichal, Thomas; Ohata, Keiichi; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Kobiyama, Kouji; Lekeux, Pierre; Coban, Cevayir; Akira, Shizuo; Ishii, Ken J.; Bureau, Fabrice; Desmet, Christophe J. // Nature Medicine;Aug2011, Vol. 17 Issue 8, p996 

    Aluminum-based adjuvants (aluminum salts or alum) are widely used in human vaccination, although their mechanisms of action are poorly understood. Here we report that, in mice, alum causes cell death and the subsequent release of host cell DNA, which acts as a potent endogenous immunostimulatory...

  • Deferoxamine Compensates for Decreases in B Cell Counts and Reduces Mortality in Enterovirus 71-Infected Mice. Yajun Yang; Jing Ma; Jinghui Xiu; Lin Bai; Feifei Guan; Li Zhang; Jiangning Liu; Lianfeng Zhang // Marine Drugs;Jul2014, Vol. 12 Issue 7, p4086 

    Enterovirus 71 is one of the major causative agents of hand, foot and mouth disease in children under six years of age. No vaccine or antiviral therapy is currently available. In this work, we found that the number of B cells was reduced in enterovirus 71-infected mice. Deferoxamine, a marine...

  • B cells for cancer immunotherapy. Deng, Jiusheng; Galipeau, Jacques // OncoImmunology;Oct2014, Vol. 3 Issue 10, pN.PAG 

    We have engineered a novel fusion cytokine named GIFT4 derived from GM-CSF and IL-4, and displaying robust gain-of-function immunostimulatory effects on B cells. GIFT4-programmed B cells have a unique identity and potent capacity to elicit a tumoricidal - cell response, thus comprising a novel B...

  • Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Gor, Dennis O.; Xuedong Ding; Qing Li; Sultana, Dilara; Mambula, Salamatu S.; Bram, Richard J.; Greenspan, Neil S. // Biology Direct;2011, Vol. 6 Issue 1, p9 

    Background: B lymphocyte stimulator (BLyS) is a member of the tumor necrosis factor superfamily of ligands that mediates its action through three known receptors. BLyS has been shown to enhance the production of antibodies against heterologous antigens when present at elevated concentrations,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics